ST Harris, JY Reginster, C Harley, WA … - Bone, 2009 - Elsevier This large study included women ≥ 45 years old, newly prescribed monthly oral
ibandronate or weekly oral alendronate or risedronate, and without malignancy or
Paget's disease of bone. The primary analysis included patients who were ... Cited by 10 - Related articles - All 35 versions
S Malozowski - Annals of Internal Medicine, 2008 - Am Coll Physicians We are all aware that a particular study design will be able to answer a set of
questions, and that no single study can answer all of the questions. An
extensive literature discusses different approaches for designing clinical ... Cited by 2 - Related articles - All 4 versions
SM Ryan, X Wang, G Mantovani, CT Sayers, … - Journal of Controlled Release, 2009 - Elsevier Salmon calcitonin (sCT) was conjugated via its N-terminal cysteine to a
comb-shaped end-functionalized poly(poly(ethylene glycol) methyl ether
methacrylate) (PolyPEG®, 6.5 kDa), and to linear PEG (5 kDa). Conjugate ... Cited by 1 - Related articles - All 2 versions
S Boonen - Current Medical Research & Opinion, 2009 - informahealthcare.com Osteoporosis is a chronic disease that presents a large economic burden both on
the affected individual and on society. Osteoporotic fractures are a cause of
significant morbidity and mortality. Given the high prevalence of ... Related articles - All 6 versions
S Boonen, R Kay, C Cooper, P Haentjens, D … - International Journal of Clinical Practice, 2009 - interscience.wiley.com Disclosures Steven Boonen has received research funding from GlaxoSmithKline,
Merck, Novartis, Procter and Gamble Pharmaceuticals, Roche, and sanofi-aventis.
No funding was received in relation to this study. Richard Kay has received ... Related articles
AA Fisher, ED O'Brien, MW Davis - Bone, 2009 - Elsevier The purposes of this study were to analyse trends in hip fracture (HF)
epidemiology over a 13-year period (1994–2007) in the Australian Capital
Territory (ACT), to assess the potential impact of concurrent changes in ... Related articles - All 28 versions
A Abelson, JD Ringe, DT Gold, JL Lange, T … - Osteoporosis International - Springer Abstract Summary There are differences in the risk profile of patients
prescribed alendronate, risedronate, or ibandronate. Observed reductions in
fracture incidence over time suggest that the effectiveness of each ... Related articles - All 2 versions
MB O'Connell, SF Vondracek, CN Klein - ashpadvantage.com Pharmacists. The American Society of Health- System Pharmacists is accredited by
the Accreditation Council for Pharmacy Education as a provider of con- tinuing
pharmacy education. This monograph provides 2.0 hours (0.2 CEUs) of ... Related articles - View as HTML - All 3 versions
SA Foster, KA Foley, ES Meadows, JA … - BMC Women's Health, 2008 - ncbi.nlm.nih.gov This study was conducted using a retrospective cohort design. Female
beneficiaries (45 years and older) with at least one claim for raloxifene or a
bisphosphonate in 2003 through 2005 and continuous enrollment in the ...
